Collateral Effect of Covid-19 on Stroke Evaluation in the United States

Akash P. Kansagra, M.D. Manu S. Goyal, M.D. Washington University School of Medicine, St. Louis, MO kansagra@wustl.edu

Scott Hamilton, Ph.D. Gregory W. Albers, M.D. Stanford University, Stanford, CA

The effect of the Covid-19 pandemic on medical care for conditions other than Covid-19 has been difficult to quantify.1Any decrease in care for patients with acute conditions such as ischemic stroke may be consequential because timely treatment may decrease the incidence of disability

Read more here : https://www.nejm.org/doi/full/10.1056/NEJMc2014816